Parker, CONCT07032662Now EnrollingIRB Ready

Chronic Inflammatory Demyelinating Polyneuropathy Clinical Trial in Parker, CO

Access cutting-edge chronic inflammatory demyelinating polyneuropathy treatment through this clinical trial at a research site in Parker. Study-provided care at no cost to qualified participants.

Sponsored by Immunovant Sciences GmbH

Quick Self-Assessment

See if you qualify for this Parker location

Preparing your pre-screening questions...

Expert Care in Parker

Access chronic inflammatory demyelinating polyneuropathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic inflammatory demyelinating polyneuropathy treatment provided free

Apply for This Parker Location

Check if you qualify for this chronic inflammatory demyelinating polyneuropathy clinical trial in Parker, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Parker

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Parker site if eligible
  4. 4Begin participation

About This Chronic Inflammatory Demyelinating Polyneuropathy Study in Parker

This is a Phase 2b study to evaluate the efficacy and safety of IMVT-1402 in adults with CIDP.

Sponsor: Immunovant Sciences GmbH

Who Can Participate

Inclusion Criteria

Have met clinical diagnostic criteria for typical CIDP or one of the following CIDP variants: multifocal CIDP or motor CIDP per the 2021 European Academy of Neurology/Peripheral Nerve Society (EAN/PNS) Guideline on Diagnosis and Treatment of CIDP.
Have electrodiagnostic test results supporting the diagnosis of CIDP per the EAN/PNS guideline on diagnosis and treatment of CIDP.
Are currently on, and have been receiving chronic, stable doses of systemic corticosteroids (i.e., daily or every other day oral or pulse regimen), or immunoglobulin therapy (IVIg or SCIg) ± low dose oral corticosteroids for at least 3 months for the treatment of CIDP at the time of the Screening Visit. Additional inclusion criteria are defined in the protocol.

Exclusion Criteria

Have current or prior history of IgM paraproteinemia with or without anti-myelin-associated-glycoprotein antibodies.
Have distal, sensory, or focal CIDP, or have a diagnosis of autoimmune nodopathy per t

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Parker?

Yes, this clinical trial (NCT07032662) has an active research site in Parker, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Inflammatory Demyelinating Polyneuropathy Treatment Options in Parker, CO

If you're searching for chronic inflammatory demyelinating polyneuropathy treatment options in Parker, CO, this clinical trial (NCT07032662) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Parker research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic inflammatory demyelinating polyneuropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic inflammatory demyelinating polyneuropathy clinical trials near you to find additional studies recruiting in your area.

More Multiple Myeloma Trials in Parker, CO

See all multiple myeloma clinical trials recruiting in Parker — not just this study.

Browse Multiple Myeloma Trials in Parker →

Browse More Trials by Condition

Multiple Myeloma TrialsFollicular Lymphoma TrialsNeuropathy TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Parker?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Parker, CO